Loading...
Standard BioTools Inc.
FLDM•NASDAQ
HealthcareMedical - Diagnostics & Research
$3.71
$-0.28(-7.02%)
Standard BioTools Inc. (FLDM) Financial Performance & Statements
Review Standard BioTools Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
64.03%
↑ 64.03%
Operating Income Growth
-128.77%
↓ 128.77%
Net Income Growth
-147.67%
↓ 147.67%
Operating Cash Flow Growth
-231.40%
↓ 231.40%
Operating Margin
-82.21%
↓ 82.21%
Gross Margin
47.04%
↑ 47.04%
Net Profit Margin
-78.24%
↓ 78.24%
ROE
-27.57%
↓ 27.57%
ROIC
-26.65%
↓ 26.65%
Standard BioTools Inc. (FLDM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Standard BioTools Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $46.72M | $44.97M | $37.20M | $45.54M |
| Cost of Revenue | $24.81M | $21.71M | $22.30M | $21.35M |
| Gross Profit | $21.91M | $23.26M | $14.91M | $24.19M |
| Gross Profit Ratio | $0.47 | $0.52 | $0.40 | $0.53 |
| R&D Expenses | $14.05M | $13.16M | $19.22M | $15.98M |
| SG&A Expenses | $37.59M | $34.40M | $37.67M | $46.94M |
| Operating Expenses | $51.64M | $54.98M | $56.90M | $62.92M |
| Total Costs & Expenses | $76.45M | $76.69M | $79.19M | $84.28M |
| Interest Income | $0.00 | $3.94M | $4.44M | $5.17M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $3.43M | $3.86M | $5.19M |
| EBITDA | -$32.82M | -$23.23M | -$41.81M | -$36.60M |
| EBITDA Ratio | -$0.70 | -$0.52 | -$1.02 | -$0.74 |
| Operating Income | -$32.82M | -$31.72M | -$41.99M | -$38.73M |
| Operating Income Ratio | -$0.70 | -$0.71 | -$1.13 | -$0.85 |
| Other Income/Expenses (Net) | -$983000.00 | $4.90M | $4.86M | $28.15M |
| Income Before Tax | -$33.80M | -$26.82M | -$45.66M | -$32.03M |
| Income Before Tax Ratio | -$0.72 | -$0.60 | -$1.23 | -$0.70 |
| Income Tax Expense | -$272000.00 | $118000.00 | $55000.00 | $128000.00 |
| Net Income | -$34.07M | -$26.94M | -$45.72M | -$32.16M |
| Net Income Ratio | -$0.73 | -$0.60 | -$1.23 | -$0.71 |
| EPS | -$0.09 | -$0.07 | -$0.12 | -$0.11 |
| Diluted EPS | -$0.09 | -$0.07 | -$0.12 | -$0.11 |
| Weighted Avg Shares Outstanding | $374.54M | $371.54M | $372.33M | $294.13M |
| Weighted Avg Shares Outstanding (Diluted) | $374.54M | $371.54M | $372.33M | $294.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan